in3

in3

Details

DC Role: 
Project Partner
Duration: 
1 Jan 2017 - 31 Dec 2021
Client: 
Marie Skłodowska-Curie Action - Innovative Training Network (H2020)

ABOUT THIS PROJECT

The Marie Skłodowska-Curie Innovative Training Network in3 aims to drive the synergistic development and utilisation of in vitro and in silico tools for human chemical and nanomaterial safety assessment. State-of-the-art human induced pluripotent stem cells research, cheminformatics, mechanistic toxicology and biokinetics are integrated safety assessment approaches. DC is hosting one of the 15 PhD students working on data management and integration, harmonization of analysis workflows and biomarker identification for key events of adverse outcome pathways. Recruitment for this and other positions in the network is still ongoing.

Latest Tweets

Edelweiss Connect (Yesterday)
Taxila™ is a platform that aggregates the tons of data produced every day in natural text & converts it to actionab… https://t.co/iUkjdNUz27
Edelweiss Connect (Yesterday)
Our #saferworldbydesign webinar series began last week with The Safe by Design (SbD) concept for nanomaterials and… https://t.co/GCs7h8Tbvf
Edelweiss Connect (2 weeks ago)
https://t.co/2D6ImSLzpd https://t.co/5VrfUGb5OO
Edelweiss Connect (2 weeks ago)
Safe by Design concept and implementation regarding complex substances - interactive webinar presented by… https://t.co/T89c97EBQL
Edelweiss Connect (4 weeks ago)
Edelweiss Connect and @Biopredic_Intl held their first practical training in integrated approaches to testing and a… https://t.co/V5xFQ5q4a8

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA